Irreversible Cardiac Changes After Dexamethasone Treatment for Bronchopulmonary Dysplasia
Overview
Overview
Journal
Pediatr Cardiol
Specialties
Cardiology & Vascular Diseases
Pediatrics
Pediatrics
Date
2001 Jul 17
PMID
11455412
Citations
1
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Dose-related cardiac outcomes in response to postnatal dexamethasone treatment in premature lambs.
Vrselja A, Pillow J, Bensley J, Ahmadi-Noorbakhsh S, Noble P, Black M Anat Rec (Hoboken). 2023; 308(4):1214-1228.
PMID: 36924351 PMC: 11889478. DOI: 10.1002/ar.25202.
Muscle ring finger 1 mediates cardiac atrophy in vivo.
Willis M, Rojas M, Li L, Selzman C, Tang R, Stansfield W Am J Physiol Heart Circ Physiol. 2009; 296(4):H997-H1006.
PMID: 19168726 PMC: 2670686. DOI: 10.1152/ajpheart.00660.2008.
References
1.
Werner J, Sicard R, Hansen T, Solomon E, Cowett R, Oh W
. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr. 1992; 120(2 Pt 1):286-91.
DOI: 10.1016/s0022-3476(05)80446-9.
View
2.
Tsukahara H, Watanabe Y, Yasutomi M, Kobata R, Tamura S, Kimura K
. Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants. Biol Neonate. 1999; 76(5):283-90.
DOI: 10.1159/000014170.
View
3.
Bensky A, Kothadia J, Covitz W
. Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics. 1996; 97(6 Pt 1):818-21.
View
4.
Papile L, Tyson J, Stoll B, Wright L, Donovan E, Bauer C
. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med. 1998; 338(16):1112-8.
DOI: 10.1056/NEJM199804163381604.
View
5.
Brozanski B, Jones J, Gilmour C, Balsan M, Vazquez R, Israel B
. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr. 1995; 126(5 Pt 1):769-76.
DOI: 10.1016/s0022-3476(95)70410-8.
View